Glycine Inhibition of Asparaginase
- 13 March 1970
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 167 (3924) , 1512-1513
- https://doi.org/10.1126/science.167.3924.1512
Abstract
Administration of either Escherichia coli asparaginase or guinea pig serum to C3H/HE mice with the 6C3HED lymphosarcoma is followed by depression of glycine in the tumor. This decrease in cellular glycine concentration does not occur in a tumor resistant to asparaginase. The inhibition of the lymphosarcoma by asparaginase can be reversed by intraperitoneal injection of asparagine or glycine. This reversal appears to be specific because lysine, threonine, serine, and aspartic acid were ineffective. Loss of cellular glycine may be more important than loss of asparagine because of the requirement for glycine in purine synthesis.Keywords
This publication has 7 references indexed in Scilit:
- DIVISION OF MICROBIOLOGY: L‐ASPARAGINASE: THE EVOLUTION OF A NEW TUMOR INHIBITORY AGENT*Transactions of the New York Academy of Sciences, 1968
- Enzymes in cancer. Asparaginase from chicken liverBiochemical Journal, 1967
- A Comparison of Concurrent and Delayed Tests for Antitumor Activity of L-Asparaginase.Experimental Biology and Medicine, 1967
- Tumor inhibitory effect of l-asparaginase from Escherichia coliArchives of Biochemistry and Biophysics, 1964
- EVIDENCE THAT THE L-ASPARAGINASE OF GUINEA PIG SERUM IS RESPONSIBLE FOR ITS ANTILYMPHOMA EFFECTSThe Journal of Experimental Medicine, 1963
- EVIDENCE THAT THE L-ASPARAGINASE OF GUINEA PIG SERUM IS RESPONSIBLE FOR ITS ANTILYMPHOMA EFFECTSThe Journal of Experimental Medicine, 1963
- REGRESSION OF TRANSPLANTED LYMPHOMAS INDUCED IN VIVO BY MEANS OF NORMAL GUINEA PIG SERUMThe Journal of Experimental Medicine, 1953